Foghorn Therapeutics Inc (FHTX)
Cost of Revenue
$21.04M
TTM · Period ending: · USD
FHTX Cost of Revenue
Latest reported$21.04Mperiod ending
Latest reported$21.04Mperiod ending
FHTX TTM Cost of Revenue ($11.29M → $21.04M)
TTM cost of revenue
High-resolution chart · PNG
FHTX cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 21,042,000 | |
| 21,942,000 | |
| 21,704,000 | |
| 20,902,000 | |
| 900,000 | |
| 0 | |
| 0 | |
| 852,000 | |
| 27,103,000 | |
| 56,351,000 | |
| 56,351,000 | |
| 83,707,000 | |
| 84,384,000 | |
| 81,110,000 | |
| 105,618,000 | |
| 99,873,000 | |
| 93,439,000 | |
| 86,107,000 | |
| 80,325,000 | |
| 58,425,000 | |
| 37,931,000 | |
| 19,289,000 | |
| 563,000 | |
| 0 | |
| 11,292,000 | |
| 11,292,000 | |
| 11,292,000 | |
| 11,292,000 | |
| 0 |